Wyeth Dual HRT Launch: Low-Dose Premarin, Prempro Available This Summer
Executive Summary
The approval of lower-dose Premarin means that Wyeth will be able to launch the .45 mg estrogen therapy at the same time as lower-dose Prempro
You may also be interested in...
Prempro Low(er) Clears FDA: .3 mg/1.5 mg Is Start Dose For Osteoporosis
Wyeth's Prempro osteoporosis prevention treatment should begin with .3 mg conjugated estrogens/1.5 mg medroxyprogesterone following FDA approval of the lowest dose of the hormone therapy June 4
Prempro Low(er) Clears FDA: .3 mg/1.5 mg Is Start Dose For Osteoporosis
Wyeth's Prempro osteoporosis prevention treatment should begin with .3 mg conjugated estrogens/1.5 mg medroxyprogesterone following FDA approval of the lowest dose of the hormone therapy June 4
Wyeth/Amgen Enbrel Adds 25,000 Patients In Q1; Prevnar Back Orders Cleared
Improved supply for Wyeth/Amgen's Enbrel is allowing for the first significant increase in the number of patients on the TNF inhibitor in more than a year